Wang Xiao-Yun, Li Xiao-Yu, Deng Ai-Jing, Bo Zhi-Yun
Department of Gynecology, The Second Clinical Medical College, Guangzhou University of TCM, Guangzhou 510120, Guangdong Province, China.
Zhongguo Zhen Jiu. 2010 Nov;30(11):913-7.
To observe the therapeutic effects between abdominal acupuncture and Deanxit for treatment of menopause depressive disorder, and to explore the efficacy and safety of abdominal acupuncture.
Sixty cases were randomly divided into an observation group and a control group, 30 cases in each. The observation group was treated with abdominal acupuncture at Zhongwan (CV 12), Xiawan (CV 10), Qihai (CV 6) and Guanyuan (CV 4), etc. The control group was treated with oral administration of Deanxit. The patients in both groups were treated for 4 weeks and followed up for another 4 weeks, and they were evaluated by Hamilton Depression Scale (HAMD) every couple weeks.
The total HAMD scores of 2 and 4 weeks treatments and 2 and 4 weeks follow-up were all reduced in both groups (all P < 0.01). The total scores of 2 and 4 weeks follow-up in observation group were lower than those in control group, with significant differences in statistical analysis (both P < 0.05). Compared with the clinical therapeutic effect of both groups after 4 weeks treatment, there was no significant difference (P > 0.05), however, after 4 weeks follow-up, the therapeutic effect in observation group was superior to that in control group, with significant difference in statistical analysis (P < 0.05). The safety indexes before and after treatment of both groups were normal, and the adverse reaction rate in observation group was much lower than that in control group (P < 0.05).
Abdominal acupuncture is an effective and safe method for menopause depressive disorder, it improves the menopause depressive symptoms with persistent action, less symptoms relapse and adverse reactions.
观察腹针与黛力新治疗更年期抑郁症的疗效,探讨腹针治疗该病的有效性和安全性。
将60例患者随机分为观察组和对照组,每组30例。观察组采用腹针针刺中脘(CV12)、下脘(CV10)、气海(CV6)、关元(CV4)等穴位;对照组口服黛力新。两组患者均治疗4周,再随访4周,每两周采用汉密尔顿抑郁量表(HAMD)进行评定。
两组治疗2周、4周及随访2周、4周时HAMD总分均降低(均P<0.01)。观察组随访2周、4周时总分低于对照组,差异有统计学意义(均P<0.05)。两组治疗4周时临床疗效比较,差异无统计学意义(P>0.05);随访4周时,观察组疗效优于对照组,差异有统计学意义(P<0.05)。两组治疗前后安全性指标均正常,观察组不良反应发生率低于对照组(P<0.05)。
腹针治疗更年期抑郁症安全有效,能改善更年期抑郁症状,且作用持久,症状复发少,不良反应少。